In a groundbreaking study, Stanford researchers reveal that heart attack deaths have plummeted by 89% since 1970, but deaths from other heart conditions like heart failure and irregular heartbeats are surging. Discover the alarming new trends in heart disease mortality.
The FDA has approved lenacapavir, a groundbreaking antiviral drug for HIV prevention developed by biochemist Wesley Sundquist. Learn how this drug could change the future of HIV treatment and prevention.
Groundbreaking research on axolotls reveals how retinoic acid plays a key role in limb regeneration, paving the way for advancements in regenerative medicine for humans.
Researchers at the Peter Doherty Institute have made a groundbreaking discovery that makes the HIV virus visible, paving the way for potential cures. This innovative approach using lipid nanoparticles could revolutionize treatment.
In an unprecedented medical achievement, a child with a rare genetic disorder receives a customized CRISPR gene therapy, paving the way for future treatments of similar conditions.
In a groundbreaking achievement, scientists have developed the first gene-editing medicine tailored for a baby suffering from a rare DNA condition. After successful treatments, KJ Muldoon is now healthier and ready to go home, showcasing a promising future for gene therapies.
As organ shortages persist, scientists explore xenotransplantation — transplanting animal organs into humans. Discover the groundbreaking history and future potential of this life-saving innovation.
In a groundbreaking case, a 6-month-old baby boy named KJ was treated with a personalized CRISPR gene-editing therapy, correcting a dangerous mutation before it could threaten his life. This innovative approach promises hope for similar cases.
In a historic move, the FDA has approved the first-ever blood test designed to diagnose Alzheimer's disease, marking a significant advancement in early detection and treatment options for patients.
A baby diagnosed with a rare genetic disorder has shown remarkable improvement after receiving an experimental gene editing treatment tailored just for him. This groundbreaking therapy offers hope for others with similar conditions.
